{"entity":{"type":"insider","cik":"0001614741","url":"/insider/0001614741","json_url":"/insider/0001614741.json","name":"Lefebvre Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":12,"first":"2020-12-21","last":"2025-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Lefebvre Eric","source":"filing","n_filings":12,"first_seen":"2020-12-21","last_seen":"2025-01-22"}],"transactions":[{"id":4896671,"accession":"0001746473-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-25-000003","line_url":"/filing/0001746473-25-000003#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18478.0,"shares_display":"18,478","price_per_share":11.2011,"price_display":"11.20","price_state":"stated","total_value":206973.9258,"total_display":"206,973.93","total_whole":"206,974","shares_owned_after":194574.0,"shares_owned_after_display":"194,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-22","scope":"insider"},{"id":2802738,"accession":"0001746473-24-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000129","line_url":"/filing/0001746473-24-000129#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12319.0,"shares_display":"12,319","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":142407.64,"total_display":"142,407.64","total_whole":"142,408","shares_owned_after":213052.0,"shares_owned_after_display":"213,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2873500,"accession":"0001746473-24-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000002","line_url":"/filing/0001746473-24-000002#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10295.0,"shares_display":"10,295","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":177382.85,"total_display":"177,382.85","total_whole":"177,383","shares_owned_after":156920.0,"shares_owned_after_display":"156,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8154923,"accession":"0001209191-23-042831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042831","line_url":"/filing/0001209191-23-042831#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22321.0,"shares_display":"22,321","price_per_share":18.0091,"price_display":"18.01","price_state":"stated","total_value":401981.1211,"total_display":"401,981.12","total_whole":"401,981","shares_owned_after":167215.0,"shares_owned_after_display":"167,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8679129,"accession":"0001209191-23-022374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-022374","line_url":"/filing/0001209191-23-022374#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11245.0,"shares_display":"11,245","price_per_share":26.5209,"price_display":"26.52","price_state":"stated","total_value":298227.5205,"total_display":"298,227.52","total_whole":"298,228","shares_owned_after":145786.0,"shares_owned_after_display":"145,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":8625864,"accession":"0001140361-23-002784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-002784","line_url":"/filing/0001140361-23-002784#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67500.0,"shares_display":"67,500","price_per_share":34.4834,"price_display":"34.48","price_state":"stated","total_value":2327629.5,"total_display":"2,327,629.50","total_whole":"2,327,630","shares_owned_after":76926.0,"shares_owned_after_display":"76,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":6343345,"accession":"0001140361-22-046569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-046569","line_url":"/filing/0001140361-22-046569#line-2","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10887.0,"shares_display":"10,887","price_per_share":19.1024,"price_display":"19.10","price_state":"stated","total_value":207967.8288,"total_display":"207,967.83","total_whole":"207,968","shares_owned_after":144426.0,"shares_owned_after_display":"144,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6127109,"accession":"0001209191-22-054747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054747","line_url":"/filing/0001209191-22-054747#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.0482,"price_display":"25.05","price_state":"stated","total_value":125241.0,"total_display":"125,241.00","total_whole":"125,241","shares_owned_after":133437.0,"shares_owned_after_display":"133,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6704915,"accession":"0001567619-22-013995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013995","line_url":"/filing/0001567619-22-013995#line-1","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":138436.0,"shares_owned_after_display":"138,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-13","scope":"insider"},{"id":4571314,"accession":"0001209191-21-042577","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-042577","line_url":"/filing/0001209191-21-042577","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":28.865696592,"price_display":"28.87","price_state":"stated","total_value":360821.2074,"total_display":"360,821.21","total_whole":"360,821","shares_owned_after":140830.0,"shares_owned_after_display":"140,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-22","scope":"insider","n_lines":3},{"id":5521397,"accession":"0001209191-21-022161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-022161","line_url":"/filing/0001209191-21-022161","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":39.41421976,"price_display":"39.41","price_state":"stated","total_value":492677.747,"total_display":"492,677.75","total_whole":"492,678","shares_owned_after":150715.0,"shares_owned_after_display":"150,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-19","scope":"insider","n_lines":2},{"id":2601872,"accession":"0000899243-20-034780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034780","line_url":"/filing/0000899243-20-034780","is_derivative":false,"issuer_cik":"0001614741","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614741","owner_cik":"0001614741","owner_name":"Lefebvre Eric","owner_display_name":"Lefebvre Eric","owner_url":"/insider/0001614741","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":26.5401376,"price_display":"26.54","price_state":"stated","total_value":331751.72,"total_display":"331,751.72","total_whole":"331,752","shares_owned_after":167792.0,"shares_owned_after_display":"167,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-21","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001746473","name":"PLIANT THERAPEUTICS, INC.","url":"/issuer/0001746473","role":"Officer (Chief Medical Officer)","n_filings":12,"first_seen":"2020-12-21","last_seen":"2025-01-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614741","retrieved_at":"2026-08-24T01:48:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}